Zobrazeno 1 - 10
of 44
pro vyhledávání: '"M Arenere"'
Autor:
MA Allende Bandres, M Arenere Mendoza, P Gomez Rivas, MA Alcacera Lopez, I Varela Martinez, R Fresquet Molina, A Frutos Perez-Surio, L Cazorla Poderoso, T Salvador Gomez, JM Vinuesa Hernando, MDLR Garcia Osuna
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1aa2031a1de46eb40406f8a62a917a8f
https://doi.org/10.1136/ejhpharm-2023-eahp.174
https://doi.org/10.1136/ejhpharm-2023-eahp.174
Autor:
L Sopena, B Bonaga, A Gonzalo, B Obon, R Gracia, R Fresquet, A Merchan, I Varela, A Mª Angeles, M Arenere
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98b139b4e8f81d3aaee1c5fa6bd958b5
https://doi.org/10.1136/ejhpharm-2022-eahp.170
https://doi.org/10.1136/ejhpharm-2022-eahp.170
Autor:
V Acín Garcés, C Seral García, JM Vinuesa Hernando, R Gracia Piquer, E Morte Romea, R Fresquet Molina, M. Arenere Mendoza, Mercedes Gimeno
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Clostridium difficile disease (CDD) is the leading cause of infectious diarrhoea in the hospital environment. Aim and objectives The objective was to evaluate the characteristics of patients with CDD prior to the implementat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3796f2514e1159c4379ae27a7905c4d1
https://doi.org/10.1136/ejhpharm-2021-eahpconf.83
https://doi.org/10.1136/ejhpharm-2021-eahpconf.83
Autor:
R Fresquet Molina, V Acín Garcés, M. Arenere Mendoza, Mercedes Gimeno, C Seral García, JM Vinuesa Hernando, E Morte Romea, R Gracia Piquer
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Clostridium difficile disease (CDD) is the main cause of nosocomial diarrhoea. Aim and objectives To evaluate the adequacy of treatment of CDD prior to implementation of the checklist for the diagnosis and treatment of CDD.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f795338947b5527aaa91d2797e8ad479
https://doi.org/10.1136/ejhpharm-2021-eahpconf.80
https://doi.org/10.1136/ejhpharm-2021-eahpconf.80
Autor:
MJ Nebot Villacampa, MA Alcácera López, JM Vinuesa Hernando, I Varela Martínez, R Gracia Piquer, T Salvador Gómez, M. Arenere Mendoza, R Fresquet Molina, FJ Campos Montellano, M Galindo Allueva
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Since the first biosimilar drug was authorised, medicine agencies have promoted their use. However, interchangeability or switching are different in each country, creating disparity in their use. Aim and objectives To measur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac8137e643d86d9020a85d04826d624a
https://doi.org/10.1136/ejhpharm-2020-eahpconf.258
https://doi.org/10.1136/ejhpharm-2020-eahpconf.258
Autor:
B Bonaga Serrano, N. Berenguer Torrijo, T Salvador Gómez, M. Arenere Mendoza, P Luque Gómez, L. Sáez-Benito Suescun, I Puértolas Tena
Publikováno v:
Eur J Hosp Pharm
BACKGROUND: Linezolid is an antibiotic with a broad spectrum of activity against all clinically important Gram +bacteria, including methicillin-resistant staphylococcus aureus and vancomycin-resistant enterococci. Standard dosing is prescribed for cr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d0d08482fb781e52cc1054aafe4e8d7
https://europepmc.org/articles/PMC7535392/
https://europepmc.org/articles/PMC7535392/
Autor:
A. Gutierrez Samper, A. Alonso Llorente, E. Lara Navarro, M. Arenere Mendoza, M.A. Julian Anson, I Puértolas Tena, B. Boreaga Serrano, M. Fabre Estremera
Publikováno v:
Clinica Chimica Acta. 493:S712
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::958672208d84804294b52b1c794c147e
https://doi.org/10.1016/j.cca.2019.03.1574
https://doi.org/10.1016/j.cca.2019.03.1574
Autor:
Merchán, A., SOPENA, L., Bandrés, M. A. Allende, López, M. A. Alcácera, Mendoza, M. Arenere, Pardo, I. Navarro, Abad, M. P. Aibar, Gasque, M. P. Monforte, Alonso, E. Fernández, Gómez, T. Salvador
Publikováno v:
European Journal of Hospital Pharmacy; 2024 Supplement, Vol. 31, pA106-A106, 2/3p
Autor:
M.J. Rabanaque Hernández, U. Cilveti-Sánchez, M. Mendaza Beltrán, M.A. Allende-Bandrés, M. Arenere Mendoza, H. Navarro Aznárez
Publikováno v:
Farmacia Hospitalaria. 29:323-330
Resumen Objetivo Estudiar los tratamientos antirretrovirales de inicio indicados en pacientes VIH durante el periodo 2001-2003, su efectividad, supervivencia y seguridad. Metodo Estudio descriptivo retrospectivo de las variables clinicas y farmacolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::505f972c8272f6ecee55759680d9a8ef
https://doi.org/10.1016/s1130-6343(05)73687-4
https://doi.org/10.1016/s1130-6343(05)73687-4
Autor:
Llorente, A. Alonso, Navarro, E.M. Lara, Estremera, M. Fabre, Samper, A. Gutierrez, Anson, M.A. Julian, Serrano, B. Boreaga, Tena, I. Puertolas, Mendoza, M. Arenere
Publikováno v:
In Clinica Chimica Acta June 2019 493 Supplement 1:S712-S712